Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!
Google me. See my one-star reviews.
Like skulls on a beach, most from a weathered past, they warn: ‘Beware. Stay away! No guarantees here. Come only if you must.’
An awful sight. Pit in my stomach. Cold damp skin. I rack my head: ‘Who wrote this? Can I fix it?’ What did I do? What will people think?
They achieve their aim. Some people stay away. And when people do call, remembering those who felt wronged, I ask: “Are you sure you need to see me? Think about it.”
Those who do venture forth find that I care deeply about our pursuit. With their courage and my commitment we gain higher ground, where sometimes they speak of our small saga, picked up and carried on kinder winds that skulls cannot block.
But when things don’t go well and I see that single star on the screen the force slams me like a wall of water. Couldn’t they contact me directly and let me try to make things better? In the backwash I’m cut by shards blasted from my foundations.
Blood oozes: ‘Is this what I ought to be doing? Is my work ethical? How can I do better?’ The pain drives me to break open the balm contained in my trove of charts, filled with stories of people I’ve helped.
Reflection and gratitude become the unintended blessings of an angry tide, helping me clear the rubble and guiding me as I begin to rebuild.
You Might Also Enjoy...
Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!
ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?
Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?
Do antipsychotics have neurotoxic effects in youth? In this episode, we’ll be banging the drum of caution about antipsychotic use in children and adolescents.
With a growing body of evidence supporting its clinical efficacy and cost-effectiveness relative to traditional ABA approaches, the developmental model is being used with increasing prevalence across the US.
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.